Steven M. Paul, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 29,482 shares at $177.58 ($5.0M) on 2022-04-01, disclosed to the SEC on 2022-04-05.
Open-market sale of $5.0M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.04 | 253 | $42K | 0.8% |
| 2 | $168.95 | 4,948 | $836K | 16.6% |
| 3 | $168.95 | 4,948 | $836K | 16.6% |
| 4 | $169.71 | 4,872 | $827K | 16.4% |
| 5 | $169.71 | 4,872 | $827K | 16.4% |
| 6 | $171.16 | 1,235 |
| $211K |
| 4.2% |
| 7 | $171.16 | 1,235 | $211K | 4.2% |
| 8 | $172.10 | 1,434 | $247K | 4.9% |
| 9 | $172.10 | 1,434 | $247K | 4.9% |
| 10 | $173.06 | 642 | $111K | 2.2% |
| 11 | $173.06 | 642 | $111K | 2.2% |
| 12 | $174.33 | 90 | $16K | 0.3% |
| 13 | $176.51 | 526 | $93K | 1.8% |
| 14 | $176.51 | 526 | $93K | 1.8% |
| 15 | $177.58 | 825 | $147K | 2.9% |
| 16 | $177.58 | 825 | $147K | 2.9% |
| 17 | $178.60 | 175 | $31K | 0.6% |
| Total | $170.67 avg | 29,482 | $5.0M | 100% |
| Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |
| ALNY | SELL | 2020-02-11 | $3.9M | — | Filing → |